NSC109555 (DDUG; NCIC04808) is an ATP-competitive inhibitor of checkpoint kinase 2 (Chk2), with an IC50 of 200 nM in cell-free kinase assays; it inhibits Chk2 autophosphorylation and phosphorylation of its substrate histone H1 (IC50 = 240 nM) in vitro; suppresses the growth of L1210 leukemia cells and induces autophagy in vitro; enhances gemcitabine-induced cytotoxicity in MIAPaCa-2, CFPAC-1, PANC-1, and BxPC-3 pancreatic cancer cells at 1,250 nM; attenuates gemcitabine-induced Chk2 phosphorylation; and potentiates gemcitabine-induced reactive oxygen species (ROS) production in MIAPaCa-2 cells.